PHARMACOLOGICAL BASIS FOR COMBINATION THERAPY OF HYPERTENSION

被引：41
作者：
DOLLERY, CT [1 ]
机构：
[1] ROYAL POSTGRAD MED SCH, DEPT CLIN PHARMACOL, LONDON W12 0HS, ENGLAND
来源：
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY | 1977年 / 17卷
关键词：
D O I：
10.1146/annurev.pa.17.040177.001523
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：311 / 323
页数：13
相关论文
共 74 条
[11]   PROPRANOLOL INHIBITION OF RENIN SECRETION - SPECIFIC APPROACH TO DIAGNOSIS AND TREATMENT OF RENIN-DEPENDENT HYPERTENSIVE DISEASES [J].
BUHLER, FR ;
BRUNNER, HR ;
BAER, L ;
VAUGHAN, ED ;
LARAGH, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (24) :1209-+
[12]   SIDE-EFFECTS OF HYPOTENSIVE AGENTS EVALUATED BY A SELF-ADMINISTERED QUESTIONNAIRE [J].
BULPITT, CJ ;
DOLLERY, CT .
BRITISH MEDICAL JOURNAL, 1973, 3 (5878) :485-490
[13]  
BULPITT CJ, 1976, BRIT HEART J, V38, P121
[14]  
BULPITT CJ, 1974, BRIT HEART J, V36, P383
[15]   PHARMACOLOGIC BASIS OF ANTIHYPERTENSIVE THERAPY - ROLE OF VASODILATOR DRUGS [J].
CHIDSEY, CA ;
GOTTLIEB, TB .
PROGRESS IN CARDIOVASCULAR DISEASES, 1974, 17 (02) :99-113
[16]   ONE-TABLET COMBINATION DRUG-THERAPY IN TREATMENT OF HYPERTENSION [J].
CLARK, GM ;
TROOP, RC .
JOURNAL OF CHRONIC DISEASES, 1972, 25 (02) :57-&
[17]  
CRANSTON WI, 1963, LANCET, V2, P966
[18]  
DAVID NA, 1975, CURR THER RES CLIN E, V18, P741
[19]  
DAY GM, 1971, BRIT J PHARMACOL, V41, pP408
[20]  
DIXON WM, 1957, LANCET, V2, P871
12345678